ERBB2 and breast cancer: BC is a highly heterogeneous disease from a molecular perspective and is primarily characterized by the overexpression of the HER2 growth factor, estrogen receptor (ER), and progesterone receptor (PR) and mutations in the BRCA1/2 genes, with the latter associated with a higher risk of developing BC [11].